Systematic Review: Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
24 Nov, 2021 | 08:22h | UTCSummary: Selective serotonin reuptake inhibitors for stroke recovery – Cochrane Library
Original Article: Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery – Cochrane Library
Related:
RCT: Routine treatment with fluoxetine does not reduce the incidence of depression after stroke.
[Abstract Only] Randomized trial: Fluoxetine does not improve functional recovery after acute stroke
Randomized Trial: Effects of Fluoxetine on Functional Outcomes After Acute Stroke
Commentary on Twitter
Selective #serotonin reuptake inhibitors for #stroke recovery https://t.co/7R5bijz49e Updated @CochraneStroke systematic review: 'reduced risk of future depression by about a quarter, but led to a slight increase in the risk of seizures & increased the risk of bone fractures.'
— The Cochrane Library (@CochraneLibrary) November 19, 2021